AI assistant
Sending…
Xylem Inc. — Director's Dealing 2011
Nov 3, 2011
30109_dirs_2011-11-03_d6bc9092-6c49-4cae-be69-a546d8f0bd33.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Xylem Inc. (XYL)
CIK: 0001524472
Period of Report: 2011-11-01
Reporting Person: LORANGER STEVEN R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-11-01 | Common Stock | A | 166779 | $0.00 | Acquired | 232042 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-11-01 | Stock Option (Right to Buy) | $25.53 | A | 199120 | Acquired | 2012-03-08 | Common Stock (199120) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $29.57 | A | 83612 | Acquired | 2013-03-06 | Common Stock (83612) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $32.56 | A | 89235 | Acquired | 2014-03-07 | Common Stock (89235) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $23.31 | A | 250000 | Acquired | 2012-10-31 | Common Stock (250000) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $29.81 | A | 100000 | Acquired | 2015-03-10 | Common Stock (100000) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $18.63 | A | 165690 | Acquired | 2016-03-05 | Common Stock (165690) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $30.03 | A | 132265 | Acquired | 2018-10-31 | Common Stock (132265) | Direct |
| 2011-11-01 | Stock Option (Right to Buy) | $32.38 | A | 115247 | Acquired | 2018-10-31 | Common Stock (115247) | Direct |
| 2011-11-01 | Phantom Stock | $ | A | 20 | Acquired | Common Stock (20) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 50551 | Indirect |
| Common Stock | 311 | Indirect |
Footnotes
F1: As of November 1, 2011.
F2: These options are fully vested and exercisable.
F3: Each share of phantom stock represents the right to receive the cash value of 1 share of Xylem Inc. common stock.
F4: Credited shares of phantom stock are payable in cash following the director's termination of service on the board of directors or a date selected by the director.
More from Xylem Inc.
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 21
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
Apr 28
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Mar 30
Director's Dealing
2026
Mar 3